By Ghaemi

Show description

Read Online or Download Polypharmacy in Psychiatry (Medical Psychiatry, 17) PDF

Similar psychology books

Getting Started with Neurofeedback

Neurofeedback education combines the foundations of complementary drugs with the facility of electronics. it's a accomplished method that promotes development switch on the mobile point of the mind and empowers the buyer to take advantage of his or her brain as a device for private therapeutic. in the past, there has now not been a unmarried complete but easy-to-understand consultant for clinicians drawn to including neurotherapy to their perform.

Creating Spiritual And Psychological Resilience: Integrated Care In Disaster Relief Work

Developing non secular and mental Resilience explores the interface among non secular and mental care within the context of catastrophe restoration paintings, drawing upon fresh failures together with yet now not constrained to, the stories of September eleven, 2001. all of the 3 sections that make up the book are dependent round the cycle of catastrophe reaction and concentrate on the appropriate part of catastrophe restoration paintings.

Psychology of Customer Care: A Revolutionary Approach

This ebook breaks new floor on buyer care. Drawing at the author's foreign adventure and examine, it presents new insights into aiding buyers make the easiest use in their time while facing YOUR company. counsel is given on 'time shaping' for max consumer delight. severe time care components for industries as different as banks, airways, lodges, supermarkets, are outlined including many the way to scouse borrow a march on rivals via this progressive and sensible method of shopper care.

Extra info for Polypharmacy in Psychiatry (Medical Psychiatry, 17)

Example text

208–226. 13. Zetzel E. Discussion. In: Solomon P, ed. Psychiatric Drugs: Proceedings of a research conference held in Boston. New York: Grune and Stratton, 1966, pp. 75–85. 14. Sargant W. Drugs or psychotherapy? In: Solomon P, ed. Psychiatric Drugs: Proceedings of a research conference held in Boston. New York: Grune and Stratton, 1966, pp. 68–74. 15. Sarwer-Foner G (ed): The dynamics of psychiatric drug therapy. Springfield, Illinois: Charles C Thomas Publisher, 1960. 16. Semrad E, Klerman G. Discussion.

Frequently, clinicians will limit themselves to medications that are FDA-indicated for specific conditions. They do this rightly in part, because FDA indication has come to be a proxy for a certain minimum level of scientific rigor (at least two randomized clinical trials of a specific nature). They do this incorrectly because FDA ‘‘approval’’ or ‘‘indication’’ is often wrongly interpreted by physicians as ‘‘permission’’ to use a drug. This is quite important: the FDA does not approve a drug to tell a physician that it is acceptable to prescribe it for a specific condition; the FDA approves a drug to tell a pharmaceutical company that it is acceptable to market the drug for a specific condition (19).

Ostow M. The use of drugs to overcome technical difficulties in psychoanalysis. In: Sarwer-Foner G, ed. The Dynamics of Psychiatric Drug Therapy. Springfield, IL: Charles C Thomas, 1960, pp. 443–470. 12. Cole J. Psychopharmacological research in the psychoanalytic setting. In: SarwerFoner G, ed. The Dynamics of Psychiatric Drug Therapy. Springfield, IL: Charles C Thomas, 1960, pp. 208–226. 13. Zetzel E. Discussion. In: Solomon P, ed. Psychiatric Drugs: Proceedings of a research conference held in Boston.

Download PDF sample

Rated 4.53 of 5 – based on 12 votes